← Back to all trials
Completed
NCT07300839
A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age
Conditions: COVID-19, SARS-COV-2 Infection
Sex: All
Ages: 50 Years – 64 Years
Healthy volunteers: Yes
Phase: PHASE3
Enrollment: 5240
Sponsor: BioNTech SE
Location: Pinnacle Research Group, LLC Anniston Alabama
Summary
This study is designed to find out how well the COVID-19 vaccine protects people 50 to 64, who don't have any serious health problems, compared to a group that receives a vaccine that doesn't contain an ingredient to protect against COVID-19 (placebo).
Eligibility Criteria
Key Inclusion Criteria
* People who are between 50 and 64 years old at their first appointment.
* People who are healthy and, based on their medical history and a doctor's judgment, are considered suitable to join the study.
Key Exclusion Criteria
* People who had COVID-19 in the past 3 months (90 days) before their first visit.
* People who got a COVID-19 vaccine, either as part of a research study or an approved vaccine, in the last 3 months-or plans to get one during the study.
Source: ClinicalTrials.gov (NCT07300839). StuddyBuddy aggregates publicly available trial information.